Secondary Progressive Multiple Sclerosis
Authors:
- Tjalf ZiemssenTjalf Ziemssen
- Virender BhanVBVirender Bhan
- Jeremy ChatawayJCJeremy Chataway
- Tanuja ChitnisTCTanuja Chitnis
- Bruce Anthony Campbell CreeBCBruce Anthony Campbell Cree
- Eva Kubala HavrdovaEHEva Kubala Havrdova
- Ludwig KapposLKLudwig Kappos
- Pierre LabaugePLPierre Labauge
- Aaron MillerAMAaron Miller
- Jin NakaharaJNJin Nakahara
- Celia Oreja-GuevaraCOCelia Oreja-Guevara
- Jacqueline PalaceJPJacqueline Palace
Open Access
- 22 November 2022
- journal article
- review article
- Published by Wolters Kluwer Health in Neurology Neuroimmunology & Neuroinflammation
- Vol. 10 (1)
Abstract
Many challenges exist in the precise diagnosis and clinical management of secondary progressive multiple sclerosis (SPMS) because of the lack of definitive clinical, imaging, immunologic, or pathologic criteria that demarcate the transition from relapsing-remitting MS to SPMS. This review provides an overview of the diagnostic criteria/definition and the heterogeneity associated with different SPMS patient populations; it also emphasizes the importance of available prospective/retrospective tools to identify patients with SPMS earlier in the disease course so that approved disease-modifying therapies and nonpharmacological strategies will translate into better outcomes. Delivery of such interventions necessitates an evolving patient-clinician dialog within the context of a multidisciplinary team.Keywords
This publication has 55 references indexed in Scilit:
- The Transition to Secondary Progressive Multiple SclerosisInternational Journal of MS Care, 2016
- Patient reported outcomes measures in neurogenic bladder and bowel: A systematic review of the current literatureNeurourology and Urodynamics, 2014
- Diagnostic uncertainty during the transition to secondary progressive multiple sclerosisMultiple Sclerosis Journal, 2014
- Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosisMultiple Sclerosis Journal, 2012
- A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MSNeurology, 2011
- Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysisThe Lancet Neurology, 2010
- Imaging outcomes for neuroprotection and repair in multiple sclerosis trialsNature Reviews Neurology, 2009
- Secondary-progressive form of multiple sclerosis: MRI changes versus clinical status.2008
- Interferon beta-1b in secondary progressive MSNeurology, 2004
- Interferon beta-1b in secondary progressive MSNeurology, 2004